Centre caps cancer drug trade margins at 30% of MRP
The story in brief
Karnataka’s health department welcomed the Centre’s decision to cap trade margins at 30% of the MRP for non-scheduled anti-cancer drugs. The move follows an inspection revealing mark-ups of up to 50 times the procurement cost. Officials called it a significant policy change after Karnataka’s investigation.